Tất cả tài liệu

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

21 trang

A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol

6 trang